Butylcarbamoyl-(4-methylphenyl)sulfonylcarbamic acid (BioDeep_00000183292)
human metabolite blood metabolite
代谢物信息卡片
化学式: C13H18N2O5S (314.0936)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCCCNC(=O)N(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C
InChI: InChI=1S/C13H18N2O5S/c1-3-4-9-14-12(16)15(13(17)18)21(19,20)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H,14,16)(H,17,18)
描述信息
同义名列表
9 个代谢物同义名
N-Butyl-1-(N-carboxy4-methylbenzenesulphonamido)methanimidic acid; N-Butyl-1-(N-carboxy4-methylbenzenesulphonamido)methanimidate; N-Butyl-1-(N-carboxy4-methylbenzenesulfonamido)methanimidate; (butylcarbamoyl)(4-methylbenzenesulfonyl)carbamic acid; Butylcarbamoyl-(4-methylphenyl)sulphonylcarbamic acid; Butylcarbamoyl-(4-methylphenyl)sulfonylcarbamic acid; butylcarbamoyl(4-methylbenzenesulfonyl)carbamic acid; Butylcarbamoyl-(4-methylphenyl)sulphonylcarbamate; Butylcarbamoyl-(4-methylphenyl)sulfonylcarbamate
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- Shaoyu Zhang, Naining Song, Quansheng Li, Huirong Fan, Changxiao Liu. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2008 Aug; 871(1):78-89. doi:
10.1016/j.jchromb.2008.06.034
. [PMID: 18614408] - Nicoline Treijtel, Arjan Barendregt, Andreas P Freidig, Bas J Blaauboer, Jan C H van Eijkeren. Modeling the in vitro intrinsic clearance of the slowly metabolized compound tolbutamide determined in sandwich-cultured rat hepatocytes.
Drug metabolism and disposition: the biological fate of chemicals.
2004 Aug; 32(8):884-91. doi:
10.1124/dmd.32.8.884
. [PMID: 15258115] - Alexander Jetter, Martina Kinzig-Schippers, Andreas Skott, Andreas Lazar, Dorota Tomalik-Scharte, Julia Kirchheiner, Monika Walchner-Bonjean, Ursula Hering, Verena Jakob, Michael Rodamer, Wafaâ Jabrane, Dirk Kasel, Jürgen Brockmöller, Uwe Fuhr, Fritz Sörgel. Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
European journal of clinical pharmacology.
2004 May; 60(3):165-71. doi:
10.1007/s00228-004-0754-z
. [PMID: 15045499] - Ophelia Q P Yin, Sherry S L Lam, Cindy M Y Lo, Moses S S Chow. Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.
Rapid communications in mass spectrometry : RCM.
2004; 18(23):2921-33. doi:
10.1002/rcm.1704
. [PMID: 15529418] - Craig R Lee, John A Pieper, Reginald F Frye, Alan L Hinderliter, Joyce A Blaisdell, Joyce A Goldstein. Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans.
Journal of clinical pharmacology.
2003 Jan; 43(1):84-91. doi:
10.1177/0091270002239710
. [PMID: 12520632] - Craig R Lee, John A Pieper, Alan L Hinderliter, Joyce A Blaisdell, Joyce A Goldstein. Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes.
Clinical pharmacology and therapeutics.
2002 Nov; 72(5):562-71. doi:
10.1067/mcp.2002.127913
. [PMID: 12426520] - H Madsen, T P Enggaard, L L Hansen, N A Klitgaard, K Brøsen. Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide.
Clinical pharmacology and therapeutics.
2001 Jan; 69(1):41-7. doi:
10.1067/mcp.2001.112689
. [PMID: 11180037]